{"id":"W4282966850","doi":"10.1093/eurjpc/zwac107","title":"Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab","year":2022,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"American Regent; Regeneron Pharmaceuticals; National Institutes of Health; GlaxoSmithKline; HLS Therapeutics; Servier; Duke Clinical Research Institute; Astellas Pharma; Novo Nordisk; Daiichi-Sankyo; St. Jude Medical; Boston Scientific Corporation; Pfizer; York University; Cleveland Clinic; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; University of Toronto; Heart and Stroke Foundation of Canada; European Commission; Sanofi; Esperion Therapeutics; Amgen","keywords":"Alirocumab; Medicine; Ezetimibe; Acute coronary syndrome; Interquartile range; Statin; Internal medicine; Placebo; Cardiology; Cholesterol; Lipoprotein; Myocardial infarction","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002887072,0.0003476108,0.00142172,0.0003541849,0.0002620596,0.000902721,0.0002899944,0.0006649928,0.001624436],"category_scores_gemma":[0.002988292,0.0001714948,0.001297493,0.0005671219,0.000185325,0.0004377818,0.0005146436,0.0007850601,0.0002374385],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004754927,"about_ca_system_score_gemma":0.000842131,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001858208,"about_ca_topic_score_gemma":0.003941666,"domain_scores_codex":[0.9985393,0.0006683043,0.0002264144,0.0001970538,0.0002277691,0.0001411831],"domain_scores_gemma":[0.9985492,0.0003373257,0.0004512578,0.0001249371,0.0001968281,0.0003404276],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2008451,0.001920473,0.7236362,0.001200507,0.006462153,0.0001875902,0.00008600934,0.001133812,0.001565092,0.0005086322,0.005137865,0.0573166],"study_design_scores_gemma":[0.02570458,0.009324096,0.9521941,0.0003078971,0.004294943,0.0003776453,0.00007427754,0.001726627,0.001026224,0.0004924614,0.004448519,0.00002868982],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883153,0.004941772,0.0004375823,0.0004576046,0.0000897243,0.0003497528,0.002645522,0.00002715854,0.002735479],"genre_scores_gemma":[0.9916644,0.001599631,0.0008536134,0.0006550882,0.0001406525,0.0004124698,0.003680522,0.000008890962,0.0009847379],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002887072,"threshold_uncertainty_score":0.01526845,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01192085290350001,"score_gpt":0.253230899390221,"score_spread":0.241310046486721,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}